Serum BNP, PTX3, and VEGF levels are of clinical value in the diagnosis of APE‐PAH patients, and serum BNP, PTX3, and VEGF levels are positively correlated with the severity of PAH and can be used as predictors of the severity of PAH. Here, VEGFA is linked to apparent mineralocorticoid excess.